Skip to main content
HR 2548 106th Congress House Armed Forces and National Security Allergies Anthrax Armed forces reserves Commerce Communicable diseases Congress Congressional investigations Congressional reporting requirements Courts-martial and courts of inquiry Crime and Law Enforcement Defense budgets Defense contracts Drug approvals Drug industry Drug interactions Economics and Public Finance Government Operations and Politics Government contractors Health

Department of Defense Anthrax Vaccination Moratorium Act

Introduced: July 19, 1999 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 30, 1999
Referred to the Subcommittee on Health and Environment.
Jul 28, 1999
Referred to the Subcommittee on Military Personnel.
Jul 28, 1999
Executive Comment Requested from DOD.
Jul 19, 1999
Referred to the Committee on Armed Services, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 19, 1999
Sponsor introductory remarks on measure. (CR E1591-1593)
Jul 19, 1999
Introduced in House
 Plain-English summary Congressional Research Service

Department of Defense Anthrax Vaccination Moratorium Act - Expresses the sense of Congress that: (1) a single protection measure such as the mandatory anthrax vaccine immunization program should not be implemented by the Department of Defense (DOD) without regard to its effect on morale, retention, recruiting, and budget; and (2) an insufficiently proven vaccine should not be advocated as a substitute for research, development, and production of truly effective vaccines and antibiotics, adequate protective equipment, and nonproliferation measures.

Directs the Secretary of Defense to suspend implementation of the DOD anthrax vaccination program.

Requires: (1) an independent study of the effectiveness and safety of the vaccine used; and (2) a report from the Director of the National Institutes of Health to specified congressional committees on study results.

Directs the Comptroller General to conduct a study and comment to Congress on the vaccine program and the effect of the use of contractor-operated facilities for such program.

Requires expedited consideration by the respective Boards for Correction of Military Records for current or former military personnel for remedies for adverse personnel actions that were the result of the vaccine program.

States that if the Director determines that the vaccine used in the DOD program meets specified criteria, the Secretary may resume such program. Provides that if such program is resumed, the Secretary may use only newly produced vaccine for vaccinations after such resumption.

What's happening now July 30, 1999

Referred to the Subcommittee on Health and Environment.

 Committees of jurisdiction 4
 Cosponsors 2
All 2 Democratic 1 Republican 1